ANDA 72152, held by Chartwell RX. Albuterol Sulfate.
As of Nov 19, 2026, ANDA 72152 (Albuterol Sulfate), held by Chartwell RX, was first approved by FDA on Mar 23, 1989, with 6 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 23, 1989 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Albuterol SulfateEQ 4MG BASE · tablet;oral | Albuterol Sulfate | Discontinued |
| Apr 23, 1998 | Supplement 13Labeling | Approved | None posted |
| Aug 23, 1994 | Supplement 10Labeling | Approved | None posted |
| Oct 6, 1993 | Supplement 4Labeling | Approved | None posted |
| Jul 10, 1991 | Supplement 3Labeling | Approved | None posted |
| Sep 10, 1990 | Supplement 2Labeling | Approved | None posted |
| Oct 18, 1989 | Supplement 1Labeling | Approved | None posted |
| Mar 23, 1989 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters